Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+ T cells in vivo.

Florence Bayard (1) , Silvina Malmassari (1) , Qiang Deng (1) , Yu-Chun Lone (2) , Marie-Louise Michel (1)

1 PVHB - Pathogenèse des Virus de l'Hépatite B
2 Greffes d'Epitheliums et Regulation de l'Activation Lymphocytaire

We previously identified two HLA-DRB1*0101-restricted epitopes in hepatitis B virus (HBV) X protein (HBx) and in HBV envelope proteins (preS2). To evaluated their help in the development of CD8+ T-cell responses, mice transgenic for human class I and class II HLA molecules were immunized with HBV-T helper constructs. The preS2 epitope favored a well-balanced response with CD4+ and CD8+ T cells producing IFN-gamma, IL-2 and TNF-alpha. The response was focused on CD8+ T cells with the HBx epitope. Fine characterization of helper activities may meet clinical needs in terms of enhancing the potency of preventive or therapeutic polyepitope vaccines.

Domains: Immunology

Florence Bayard, Silvina Malmassari, Qiang Deng, Yu-Chun Lone, Marie-Louise Michel. Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+ T cells in vivo.. Vaccine, 2010, epub ahead of print. ⟨10.1016/j.vaccine.2010.03.026⟩. ⟨pasteur-00474284⟩